Type I phosphomannose isomerases (PMIs) are zinc-dependent monofunctional metalloenzymes catalysing the reversible isomerization of D-mannose 6-phosphate to D-fructose 6-phosphate. 5-Phospho-D-arabinonhydrazide (5PAHz), designed as an analogue of the enediolate high-energy intermediate, strongly inhibits PMI from Candida albicans (CaPMI). In this study, we report the 3D crystal structure of CaPMI complexed with 5PAHz at 1.85 A resolution. The high-resolution structure suggests that Glu294 is the catalytic base that transfers a proton between the C1 and C2 carbon atoms of the substrate. Bidentate coordination of the inhibitor explains the stereochemistry of the isomerase activity, as well as the absence of both anomerase and C2-epimerase activities for Type I PMIs. A detailed mechanism of the reversible isomerization is proposed.
Type I phosphomannose isomerases (PMIs) are zinc-dependent monofunctional metalloenzymes catalysing the reversible isomerization of D-mannose 6-phosphate to D-fructose 6-phosphate. 5-Phospho-D-arabinonhydrazide (5PAHz), designed as an analogue of the enediolate high-energy intermediate, strongly inhibits PMI from Candida albicans (CaPMI). In this study, we report the 3D crystal structure of CaPMI complexed with 5PAHz at 1.85 A resolution. The high-resolution structure suggests that Glu294 is the catalytic base that transfers a proton between the C1 and C2 carbon atoms of the substrate. Bidentate coordination of the inhibitor explains the stereochemistry of the isomerase activity, as well as the absence of both anomerase and C2-epimerase activities for Type I PMIs. A detailed mechanism of the reversible isomerization is proposed.
Keywords: Candida albicans; enzyme mechanism; inhibitor; phosphomannose isomerase; zinc metalloenzyme Phosphomannose isomerases (PMIs, E.C. 5.3.1.8) are metal-dependent aldose-ketose isomerases that catalyse the reversible isomerization of D-mannose 6-phosphate (M6P) and D-fructose 6-phosphate (F6P) in prokaryotic and eukaryotic cells [1] [2] [3] . Based on their amino acid sequence identity, PMIs have been classified into three unrelated families as proposed by Proudfoot et al. [4] : Type I, Type II and Type III families. A fourth family comprises enzymes from aerobic crenarchaeons which display an atypical dual PMI/phosphoglucose isomerase (PGI, E.C. 5.3.1.9) activity within the PGI superfamily [5, 6] . Type I PMIs are zinc-dependent monofunctional aldose-ketose isomerases and include all eukaryotic and some bacterial enzymes [4] . Type II PMIs, found only in some bacteria, are bifunctional enzymes possessing both PMI and guanosine-diphosphate-D-mannose pyrophosphorylase activities [7] . Only one Type III PMI has been reported to date, from Rhizobium meliloti [8] . While F6P is a substrate for glycolysis and gluconeogenesis, M6P is a substrate for the production of the activated mannose donor guanosine 5 0 -diphosphate D-mannose, an important precursor of several mannosylated biomolecules including glycoproteins, fungal cell wall components and bacterial exopolysaccharides [9] . PMI is further reported as essential for the survival, virulence and/or pathogenicity of some bacteria and protozoan parasites [10] [11] [12] , as well as for the cell wall integrity of yeasts including Saccharomyces cerevisiae [13] , Candida albicans [14] , Cryptococcus neoformans [15] and Aspergillus nidulans [16] . Consequently, PMI is considered as a potential target against fungal infections causing serious illness or death, notably in the case of immunodeficient individuals [17, 18] . As Type I PMIs have a high level of sequence identity, particularly in the region of the active site (Fig. S1 ) [19] , detailed structural information of these enzymes is needed for the development of species-specific inhibitors. Strong enzyme inhibitors are not only of potential therapeutic interest, but can also provide important mechanistic information. Structure determination of a complex between a transition-state or high-energy intermediate (HEI) analogue inhibitor and the target enzyme is particularly informative. PMI has substrate specificity for b-anomers, namely b-D-mannopyranose 6-phosphate (b-M6P) and b-D-fructofuranose 6-phosphate (b-F6P) [20, 21] . Isotope-exchange experiments have demonstrated that the isomerization step between M6P and F6P catalysed by PMI proceeds through a proton transfer mechanism between the two carbon atoms C1 and C2 of the substrates, creating a 1,2-cisenediolate high energy intermediate (HEI) [22] , as depicted in Fig. 1A . Other aldose-ketose isomerases are known to catalyse this hydrogen transfer through a proton transfer mechanism including triosephosphate isomerase (TIM) [23] and PGI [24, 25] , while some are reported to proceed through a metal-mediated hydride shift mechanism as for xylose isomerase [26] . Unlike PGI, the glycolytic enzyme which interconverts D-glucose 6-phosphate (G6P) and F6P, PMI does not have epimerase nor anomerase activity [20, 21, 27] and its implication in the ring opening/closing steps of b-M6P/b-F6P (Fig. 1A) has not been demonstrated to date. Despite a number of reported kinetic [2, 28] , mutagenesis [29, 30] , structural [18, 31] and modelling [19, 32] studies which led to various conclusions, the detailed mechanism of action of Type I PMIs remains unknown, and notably the nature and precise role of each of the active site residues, except for Arg304 which was firmly identified by Wells et al. [29] as an active site residue of PMI from C. albicans (CaPMI).
In 1996, Cleasby et al. [18] reported the first structure of the PMI from C. albicans (PDB 1PMI) at 1.7
A resolution, which allowed the identification of the location of the active site as well as the zinc binding site. In 2009, Sagurthy et al. reported the crystal structures of Type I Salmonella typhimurium PMI (StPMI) bound to metal atoms and F6P, together with a number of ethylene glycol molecules. In the StPMIZn-F6P structure (PDB 3H1Y), F6P is not bound to the zinc cofactor, nor to Arg274 (which corresponds to Arg304 in CaPMI). The crystal structures of Type II PMI from Helicobacter pylori (PDB 2QH5), of Type I PMI from Archeoglobus fulgidus with F6P and a number of glycerol, ethylene glycol and acetate molecules (PDB 1ZX5), and of Type I PMI from Bacillus stearothermophilus with a sulphate ion bound (PDB 1QWR) were deposited at the Protein Data Bank, but were not reported in the literature. As far as we know, no other crystal structures of PMIs are available, except for the crenarchaeons PGI/PMI which are quite different from the Types I-III families. No high-resolution crystal structure of a PMI with a bound inhibitor at the active site has been reported. In the absence of structures of complexes, theoretical approaches were attempted to investigate the mechanism. Using the polarizable mechanics procedure SIBFA (Sum of Interactions Between Fragments Ab initio computed) developed by Gresh et al., computed structures of complexes between CaPMI and the HEI analogue inhibitor 5-phospho-D-arabinonohydroxamic acid (5PAH, Fig. 1B) identified most of the active residues as well as three possible modes of coordination of the hydroxamate group to the zinc cofactor, including monodentate and bidentate coordination modes [32] , in accordance with the catalytic role proposed for the metal cofactor. Because the protein backbone was held rigid in these computational studies, we proposed the neutral form of Lys136 as the catalytic base that transfers a proton between the C1 and C2 carbons of the substrates [19] , a hypothesis which is contradicted by the present results. In this study, we report the first high-resolution X-ray (1.85 A) crystal structure of the PMI from C. albicans (CaPMI) complexed with one of its HEI analogue inhibitors, 5-phospho-D-arabinonhydrazide (5PAHz [33] , Fig. 1B ). The structure of CaPMI-5PAHz not only confirms the location of the active site, but it also highlights the role of the zinc cofactor and of each of the active site residues, including identification of the catalytic base that transfers a proton between the two carbons C1 and C2 of M6P/ F6P. The structure also clearly explains substrate and reaction specificities of Type I PMIs, as well as stereochemical outcomes of the isomerization reaction. Finally, a detailed mechanism of the isomerization reaction catalysed by type I PMIs is proposed.
Materials and methods

Expression and purification
To obtain large quantities of protein for crystallization, we produced recombinant CaPMI using Escherichia coli as a host organism. The gene coding for CaPMI was synthesized (ThermoFisher-Invitrogen, Courtaboeuf, France) and incorporated in the pRSET-C expression vector (ThermoFisherInvitrogen) between the restriction sites NheI and BamHI as described by Gowda et al. [34] for PMI from S. typhimurium, which resulted in a construct containing a polyhistidine (6xHis) N-terminal tag and 14 additional amino acids. The plasmid was used to transform E. coli BL21 (DE3) strain (Sigma-Aldrich, Steinheim, Germany). Transformed cells were grown on LB (Lysogeny Broth) agar with ampicillin (100 lgÁmL À1 ), and a preinoculum from a single colony was grown in LB at 37°C until the OD 600 reached 0.6. TB (Terrific Broth) supplemented with ampicillin (50 lgÁmL À1 ) was inoculated from the preinocculum at 1/100th and grown at 37°C until the OD 600 reached 0.6. At this stage, 0.3 mM isopropyl b-D-1-thiogalactopyranoside was added and incubation was continued at 30°C for 5-6 h. Cell collection as well as protein extraction and purification on a Ni-NTA affinity column were performed according to the published procedure [34] . The eluted protein was dialysed against a 20 mM TRIS HCl buffer, pH 8 and 20 mM NaCl, then concentrated and deposited on a mono QÒ HR 16/10 anion exchange column. A 0-1 M NaCl gradient was applied and CaPMI eluted at 150 mM NaCl. Starting from a 100 mL culture, 22.7 mg of pure CaPMI were obtained and dialysed against 20 mM TRIS buffer at pH 8.5 containing 150 mM NaCl. SDS/PAGE electrophoresis followed by Coomassie blue staining revealed a pure protein with a molecular weight around 50 kDa (Fig. S4 ). The protein band was cut out, trypsin digested and then analysed by MALDI-TOF (Matrix Assisted Laser Desorption Ionization -Time of Flight) mass spectrometry, resulting in the authentication of 39% of the protein sequence (Fig. S5 ). MALS (Multi Angle Light Scattering) analysis showed a monomeric protein with a molecular weight of 58 kDa, while the theoretical mass of CaPMI is 57.467 kDa (Fig. S6 ). Finally, western blotting using antiHis-tag antibody confirmed that the purified protein is indeed His-tagged (Fig. S7 ).
Crystallization and data collection
Crystals of PMI in complex with 5PAHz were produced by mixing concentrated protein (10 mgÁmL
À1
) containing 5 mM of 5PAHz (in 150 mM sodium chloride, 20 mM Tris, pH 8.5) with crystallization buffer (20% PEG3350, 0.2 M magnesium chloride, 0.1 M Bis Tris, pH 5.5) in a 1 : 1 ratio. Drops were equilibrated against a well of 500 lL crystallization solution at 18°C by the hanging-drop vapour-diffusion method. Crystals grew within 3 days to a size of about 0.12 mm 9 0.1 mm 9 0.03 mm and belong to space group P2 1 2 1 2 with cell dimensions a = 87.97
A, b = 107.86
A and c = 44.03 A. The crystals contain one copy of PMI per asymmetric unit, with an estimated solvent content of 42.4%. Crystals were cryoprotected in 25% PEG3350, 0.2 M magnesium chloride, 0.1 M Bis Tris, pH 5.5, 18% glycerol, 4 mM 5PAHz. Crystals were flash cooled in liquid nitrogen. Data were collected at the Proxima 1 beam line, synchrotron SOLEIL (Gif-sur-Yvette, France), at 100 K on a Dectris Pilatus 6M detector (Dectris AG, Baden-Daettwil, Switzerland). Data were indexed and processed with XDS [35] (Table 1) .
Structure determination and refinement
A molecular replacement solution with the previously determined 1.7
A model of C. albicans phosphomannose isomerase (PDB 1PMI) [18] devoid of all nonprotein atoms was found with PHASER [36] . Model building and further interpretation of the electron density map were performed with the program COOT [37] . Structural refinement was completed with REFMAC [38] . The current model consists of 440 residues (residues 2-441). A molecule of 5PAHz and one zinc ion were found in the active site of the structure. All molecular structure figures were generated with PYMOL 2.0.5 [39] , GIMP 2.6.6 [40] , CHEMDRAW Pro 12.0 (PerkinElmer Informatics, Inc., Cambridge, MA, USA) and Powerpoint softwares were also used to prepare figures.
Crystallographic data collection and refinement statistic of PMI-5PAHz complex are given in Table 1 .
Results
Crystals of the PMI-5PAHz complex were obtained by cocrystallization. X-ray diffraction data were collected at 1.85
A and the structure was solved by molecular replacement using the coordinates of the apo-protein (PDB 1PMI). The structure of the enzyme consists of three domains: two similar antiparallel b-strand domains and a helical domain. The catalytic domain (residues 11-52, 266-332) is sandwiched between a helical domain and the very similar C-terminal b-jelly roll domain ( Fig. 2A) . It has a Zn-ion bound at the bottom of a large cavity between the two sheets that seat the active site. As depicted in Fig. 2B ,C, the Znion is hexacoordinated by three oxygen and three nitrogen ligands. Two of the oxygen and two of the nitrogen ligands are provided by the sidechains from Gln111 (Oe1), His113 (Ne2), Glu138 (Oe2) and His285 (Ne2). The remaining one oxygen and one nitrogen ligands are provided by the hydrazide function of 5PAHz, which therefore is acting as a bidentate ligand. In the apo-enzyme, the coordination sphere of the Znion involves the above residues and is completed by a water molecule. The axis of the distorted Zn-octahedron is formed by the His113 Ne2 and this water molecule [18] .
Interactions of 5PAHz at the active site
The residual electron density calculated after refinement of the protein structure clearly indicated the presence of the 5PAHz inhibitor in the active site (Fig. 2D ). 5PAHz adopts an extended conformation and occupies the active site groove (Fig. 3) . The 5PAHz-phosphate group is well fixed, engaging in many hydrogen bonds with the surrounding side chains of residues Trp18 (Ne1), Ser109 (Oc), Ser109 (NH), Gln111 (Ne2), Arg304 (Ne) and Lys310 (Nf), and with two water molecules (Fig. S2) . The 5PAHz-4OH group forms a hydrogen bond to a water molecule H-bonded to Asp300 (Oe2) and Lys136 (Nf). The 5PAHz-3OH group forms hydrogen bonds with the carboxylate of Glu48 (Oe2), with Lys100 (Nf), and with a water molecule. The 5PAHz-2OH group forms hydrogen bonds with the carboxylate of Glu294 (Oe1) and with Lys100 (Nf). The remainder of the inhibitor, the hydrazide group, is directly bound to the catalytic Zn-ion, as well as to the side chains of surrounding residues: the O1 carbonyl atom coordinates the Zn-ion (2.10 A) and is H-bonded to Lys136 (Nf), the NH 2 group also coordinates the Zn-ion (2.00 A) and is Hbonded to Glu138 (Oe1), and the N1H group (mimicking the C1H group of the substrate M6P or F6P) is Hbonded to Glu294 (Oe2) with an interatomic distance dOe2ÀN1 = 2.90
A. Obviously, Glu294 appears wellpositioned with respect to N1 and C1 atoms of 5PAHz to act as the catalytic base that would transfer a proton between the respective C1 and C2 atoms of the substrate M6P or F6P. Protein and inhibitor liganding groups create a distorted octahedral coordination of the Zn-ion (Fig. 2B,C) . The 5PAHz-O1 atom is part of the octahedral plane together with Gln111 (Oe1), Glu138 (Oe2) and His285 (Ne2) and the 5PAHz-N atom replaces the axial water molecule in the native structure (Fig. 4) . It was suggested that the Zn is associated to an activated water molecule that would be displaced by the binding of a substrate [1] . This hypothesis seems to be confirmed by the binding mode of the 5PAHz inhibitor since the inhibitor displaces the Zn bound water molecule and provides two groups as ligands for the metal.
The binding of 5PAHz induces considerable conformational changes in PMI
The overall structures of the native and inhibitor bound forms of PMI are very similar. Superposition of the complete structures, however, reveals considerable shifts in the positions of the three domains with a rmsd value of 1.96 A. Individual superposition of the three domains between the two structures yields rmsd values of 0.223 A for the helical domain (residues 153-265), 0.252 and 0.206
A for the C-terminal domain (residues 2-10 and 333-441, respectively), and 0.674 and 0.882 A for the catalytic domain (residues 11-152 and 266-332, respectively). Hence, individual superposition of the helical and C-terminal domains reveals small conformational changes upon binding of 5PAHz, unlike the catalytic domain which shows large conformational changes.
Inspection of the apo-and complex structures, superposed onto their helical domains (residues 153-265; Fig. 5 , top) reveals that inhibitor binding causes considerable conformational movements of one sheet of the catalytic jelly roll and C-terminal domains (residues 2-152 and 266-441). The regions contained between residues 12-22 (b2-b3 strands), 23-59 (a1-b4-b5 strands), 97-104 (b8 strand) and 297-312 (b14-b15 strands) are pulled over to the active site pocket by several A (Fig. 5, bottom) . Indeed, the peptide segments that undergo the largest conformational movements Fig. 2 . Three-dimensional X-ray crystal structure of the complex between Candida albicans phosphomannose isomerase and HEI inhibitor 5-phosphate-D-arabinonhydrazide (CaPMI-5PAHz, PDB 5NW7): (A) cartoon presentation of the overall 3D structure; rainbow colour between Nterminus (blue) and C-terminus (red); (B) enlarged view of the Zn-binding site (some residues have been removed for clarity); (C) omit electron density map at 3r level, the refined model for 5PAHz is shown as sticks; (D) coordination sphere of the zinc cofactor (distances are given in A).
contain residues that are in direct contact with the inhibitor. For instance, the interaction between residues Trp18, Arg304 and Lys310 with the phosphate group of 5PAHz induces their displacements of 2.9, 1.7 and 5.0 A, respectively. Significant displacements are also observed for Glu48 (2.7 A), Lys100 (2.7 A), Lys136 (1.4 A), Tyr287 (3.0 A) and Glu294 (1.2 A). Indirect interaction with the inhibitor through water molecules of residues Tyr16, Asp300 and Thr308 also leads to displacements of 4.7, 2.3 and 0.7
A. The inhibitor binding causes a small displacement of 0.5 A for the Zn ion compared to the enzyme without inhibitor. Consequently, zinc liganded residues Gln111, His113 and His285 are only slightly displaced (0.3, 0.6 and 0. 4 A, respectively), while the fourth zinc ligand, Glu138, rotates by about 90°allowing its interaction with Tyr287 (2.9 A) and with the NH 2 group of the inhibitor (2.7 A). The space group of the apo-and 5PAHz-bound crystal forms are different (C2 and P2 1 2 1 2, respectively) and we cannot totally exclude that the differences between the two structures are due to their different crystal packing.
Discussion
In this study, we report the first 3D structure at 1.85
A of a PMI complexed with one of its best competitive inhibitors, namely 5PAHz (PDB 5NW7). Indeed, we measured a K i value of 1.7 lM for the competitive inhibition of CaPMI by 5PAHz whereas the K m value for M6P is 130 lM (see ref. [19] for details on kinetic assay conditions), in agreement with the reported K i values of 0.6 and 2.0 lM on human and E. coli PMIs, respectively [19] . Because 5PAHz can be classified as an analogue of the 1,2-cis-enediolate highenergy reaction intermediate, this CaPMI-5PAHz 4 . View of the active sites of native CaPMI (PDB 1PMI, grey) and CaPMI-5PAHz complex (PDB 5NW7, light blue) superposed onto their helical domains (residues 153-265). In CaPMI-5PAHz complex, the NH 2 group of inhibitor 5PAHz replaces the zinc bounded water molecule (W797) of native CaPMI. structure provides crucial mechanistic information of the M6P-F6P reversible isomerization catalysed by Type I PMIs. As depicted in Fig. 2 , the hydrazide functional group C(=O)NHNH 2 of 5PAHz appears strongly coordinated to the zinc cofactor in a bidentate manner which leads to an octahedral hexa-coordinated zinc complex. Binding of the inhibitor displaced the zinc bound water molecule in the native enzyme and further induces a 90°rotation of the zinc bound carboxylate function of Glu138 (Fig. 4) . Although Glu138 remains coordinated to the zinc cofactor, it now also interacts with Tyr287. Because 5PAHz is also a good mimic of the linear form of F6P or M6P, it appears very likely that zinc coordination of the linear substrate also occurs in a bidentate manner through its O1 and O2 oxygen atoms. Hence, the zinc cofactor plays an important dual role in catalysis. It first acts as a Lewis acid in the polarization of the C=O bond of linear F6P or M6P thus facilitating deprotonation of the C1H (F6P) or C2H (M6P) group by a nearby basic residue. Secondly, it stabilizes the binding of the 1,2-cis-enediolate HEI. Zinc bidentate coordination by O1 and O2 oxygens atoms of the substrates and HEI also clearly explain why Type I PMI, unlike PGI, does not have anomerase [20] [21] [22] 27 ] nor C2-epimerase [27] activities: rotation about the C1-C2 and C2-C3 bonds, respectively, cannot occur in this bound state. Hence, the CaPMI-5PAHz structure provides a conclusive experimental evidence to support the early hypothesis of Gracy and Noltmann who proposed that the substrate formed a bidentate ligand to the zinc cofactor, one from the carbonyl oxygen, and the second from the adjacent hydroxyl group [1] .
The CaPMI-5PAHz structure clearly identifies Glu294 as the basic residue involved in the proton transfer between the two carbons C1 and C2 of the substrate M6P or F6P. Glu294 is well-positioned for catalysing the proton transfer between the two carbon atoms with distances of 2.9 and 3.5
A between Oe2 oxygen atom of Glu294 and N1 nitrogen and C1 carbon atoms of the hydrazide function corresponding to the C1 and C2 carbon atoms of the substrate, respectively. The rather long distance of 3.5 A suggests that the Glu294 side chain possibly moves during the proton transfer. The Oe1 oxygen atom of Glu294 is hydrogen-bonded to the C3 hydroxyl group of the inhibitor with a distance of 2.6
A. Interestingly, Cleasby et al. [18] had proposed that either Glu48 or Glu294 would play the role of general base in the reaction. Our structure definitely assigns this role to Glu294. It should be noticed that both triosephosphate isomerase (TIM) and PGI use a glutamate residue to transfer a proton between the two carbons C1 and C2 of their respective substrates: Glu165 for TIM from chicken [41] and Glu357 for PGI from rabbit muscle [42] , with distances dOe2-N1 = 2.5
A and dOe2-C1 = 3.3
A for TIM-PGH (phosphoglycolohydroxamate) complex (PDB 7TIM) [43] and dOe2-N1 = 3.1 A and dOe1-C1 = 3.0 A for PGI-5PAH complex (PDB 1KOJ) [44] . As seen from the sequence alignment depicted in Fig. S1 , Glu294 is totally conserved among PMI homologues. Even for Type I PMI from Bacillus subtilisis (BsPMI) whose sequence counts only 316 residues and lacks the complete helical domain, sequence alignment with CaPMI identifies Glu183 as the catalytic base which corresponds to Glu294 in CaPMI. The structural alignment of the BsPMI (PDB 1QWR) [45] and CaPMI-5PAHz structures shows that Glu183 overlaps with Glu294 in CaPMI. Structure superposition of CaPMI-5PAHz with type II PMI from S. typhimurium (PDB 3H1M) [31] , and with archaeal PMI from A. fulgidus (PDB 1ZX5) suggests that their catalytic bases are Glu262 and Glu184, respectively (see Fig. S3 for structural alignment of these PMIs). For the hyperthermophile PMI from Thermus thermophilus (TtPMI) where Glu132 corresponds to Glu294 in CaPMI (Fig. S1 ), E132W, E132K and E132Q mutants displayed no residual activities for Fig. 6 . Structural alignments of Candida albicans PMI in complex with 5PAHz (light blue, PBD 5NW7) and: top, Salmonella typhimurium PMI in complex with F6P (yellow, PDB 3H1Y) together with a number of ethylene glycol molecules [31] ; bottom, Archeoglobus fulgidus PMI in complex with F6P (purple, PDB 1ZX5) together with a number of glycerol, ethylene glycol and acetate molecules (unpublished). Zinc atoms are represented as spheres. Glu294 (CaPMI) and Glu262 (StPMI) are visible in the top structural alignment.
M6P as compared to wild-type TtPMI, while E132D and E132A mutants displayed only 0.4% and 1.9% residual activities, respectively [46] . For the E132A mutant, the K m value is almost unchanged (0.18 vs. 0.21 mM for wild-type TtPMI), while the k cat /K m value is approximately 60-fold lower (109 vs. 6685 mM À1 Ás À1 for wild-type TtPMI), indicating that Glu132 is definitely involved in the catalytic process. Other activesite carboxylate residues of the CaPMI-5PAHz complex like Asp300, Glu48 and Glu138 can be ruled out as candidates for proton transfer: (a) Asp300 is positioned about 7 A from the hydrazide function, indirectly interacting with the C4 hydroxyl and phosphate groups of 5PAHz through water molecules, (b) Glu48 is positioned about 5
A from the hydrazide function and strongly interacts with the hydroxyl group on C3 of 5PAHz, (c) although situated at reasonable distance from the hydrazide function (3.4-3.9 A), Glu138 is very likely not basic enough because of its strong coordination to the zinc cofactor (2.0 A) as well as to the nearby Tyr287 residue (2.9 A). Finally, based on a previous polarizable molecular mechanic study of the CaPMI-5PAH complex, we reported Lys136 as a possible candidate for the catalytic base [19] . Despite that active site residues may have pK a values decreased or increased by several orders of magnitude depending on their close environment, Lys136 is thus likely protonated (Lys-NH 3 + ) and well-positioned to stabilize the 1,2-cis-enediolate HEI. Indeed, Lys136 (Nf) forms a hydrogen bond with the oxygen atom of the carbonyl group of 5PAHz, which corresponds to the oxygen atom on C2 of the substrate, with a distance of 2.9
A. Interatomic distances to C1 and N1 atoms of the inhibitors (C2 and C1 atoms of the substrate, respectively) are much higher (3.6 and 4.8 A, respectively) so that Lys136 is unlikely to act as the base that would transfer a proton between to two carbons of the substrate.
For reasons unclear to us, superimposition of S. typhimurium PMI in complex with F6P (PDB 3H1Y) [31] and CaPMI-5PAHz shows that 5PAHz and F6P do not interact at the same site. In the StPMI-F6P structure, F6P does not coordinate with the zinc, nor does it bind to Arg272 (which corresponds to the identified active site residue Arg304 in CaPMI). However, the StPMI structure reveals an ethylene glycol molecule which partly occupies the position of 5PAHz in the CaPMI structure, which might explain such a striking difference in the binding modes of F6P and 5PAHz (Fig. 6, top) . A similar conclusion might be drawn for the alignment of A. fulgidus PMI in complex with F6P (PDB 1ZX5) and CaPMI-5PAHz structures with a glycerol molecule in the archea PMI structure in place of 5PAHz in the CaPMI structure (Fig. 6, bottom) .
Comparison of the structures of the two cupin-type metal proteins CaPMI-5PAHz (PDB 5NW7) and phosphoglucose isomerase from Pyrococcus furiosus (PfPGI) in complex with 5-phospho-D-arabinonate (5PAA) [47, 48] and Mn 2+ (PDB 1X7N) [49] shows very similar metal-binding sites. Gln111, His113, Glu138, and His285 in the CaPMI structure correspond to His88, His90, Glu97 and His136 in the PfPGI structure, respectively. In the CaPMI structure, the coordination sphere of the metal-ion is completed by the hydrazide function of 5PAHz, while it is completed by a water molecule (W407) and the O1 oxygen atom of 5PAA in the PfPGI structure. Both structures display a similar distorted octahedral coordination of the Zn (CaPMI) and Mn (PfPGI) ions (Fig. 7) . However, the mechanism of PfPGI is not well understood. Some structural studies have suggested that the mechanism of PfPGI involves a direct metal-mediated hydride transfer between the C1 and C2 carbon atoms of the substrate G6P or F6P [50] , while the above study of PfPGI-5PAA proposed that a cis-enediol mechanism with Glu97 as the catalytic base should not be ruled out [49] . It appears to us still difficult to conclude about the mechanism of PfPGI. Despite that Glu97 (which corresponds to Glu138 in CaPMI) is well-positioned, it strongly interacts with the Mn-ion so that its pK a value may not be high enough to make it act as a base. Also, Glu97 in PfPGI superimposes with Glu138, but not with Glu294 in CaPMI. The only other PfPGI residue which corresponds to Glu294 in CaPMI would be Tyr99 with distances of 3.12 and 3. 47 A between the phenol oxygen atom and the O1 and C1 atoms of 5PAA (which correspond to the C1 and C2 atoms of the substrate), respectively. Clearly further studies are required to elucidate the PfPGI mechanism.
Stereochemical outcomes of the CaPMI isomerization reaction mechanism are quite instructive. In agreement with stereochemical studies of the PMI catalysed isomerization reaction [20, 24, 51] , the CaPMI-5PAHz 3D structure provides the first structural evidence for stereospecific deprotonation of the pro-S proton on C1 of F6P by Glu294 and subsequent protonation on the Si face on C2 by protonated Glu294 so as to provide M6P. Because of the bidentate coordination of the substrate by its O1 and O2 Fig. 8 . Proposed mechanism of M6P to F6P reversible interconversion catalysed by Type I PMI from Candida albicans. M6P to F6P isomerization: 1, proton abstraction from C2 of M6P by Glu294 to yield 1,2-cis-enediolate HEI1; 2, proton interconversion step between O1 and O2 of HEI1 to yield HEI2; 3, protonation at C1 (Si face) of HEI2 by Glu294 to yield F6P; 4, replacement of F6P by M6P at the active site.
oxygen atoms, deprotonation of the pro-R proton on C1 of F6P is not possible, nor is protonation on the Re face on C2 of F6P which would give G6P. The only protein residue close to the Re face of F6P, Gln111, cannot act as a catalytic base. Gln111 is further coordinated to zinc and hydrogen-bonded to the phosphate oxygen atom on C5 of the inhibitor. Hence, our results explain why linear M6P is a substrate of CaPMI and why linear G6P is not. Only b anomers of M6P and F6P, namely 6-phosphate-b-D-fructofuranose (b-F6P) and 6-phosphate-b-D-mannopyranose (b-M6P), are known as substrates of the enzyme, with a-M6P reported, at best, as a poor inhibitor [20, 22] . However, whether Type I PMI catalyses the ring opening/closing steps of cyclic substrates or not is still an open question that the CaPMI-5PAHz structure cannot addressed. Structural studies of CaPMI complexed with b-M6P or b-F6P could help to answer this question.
Mechanism of the reversible isomerization of linear M6P to linear F6P catalysed by Type I PMI from C. albicans can be described as follows (Fig. 8) . In step 1, O1 and O2 coordination of M6P to the zinc cofactor facilitates proton abstraction from C2 of M6P by Glu294 to yield the first 1,2-cis-enediolate HEI1, which is further stabilized through its interaction with zinc. Proton interconversion between O1 and O2 leads to the second 1,2-cis-enediolate HEI2 in step 2 through a likely intramolecular proton exchange mechanism. HEI2 is also strongly stabilized through its interaction with zinc as well as Lys136. In step 3, protonation at C1 (Si face) of HEI2 by protonated Glu294 yields F6P with introduction of the proton in pro-S position. In the final step 4, F6P is replaced by M6P at the active site.
In conclusion, we report in this study the first 3D crystal structure of a PMI, the Type I PMI from C. albicans, complexed to a HEI analogue inhibitor, 5-phospho-D-arabinonhydrazide 5PAHz, at 1.85 A resolution. Upon binding of the inhibitor, strong conformational movements occur in the protein, and notably for the catalytic jelly roll domain, as compared to the structure of the apo-enzyme. The CaPMI5PAHz structure identifies Glu294 as the catalytic base involved in the proton transfer between the two carbons C1 and C2 of the substrate, and revealed the role for all other conserved active site residues in the process of isomerization. The hydrazide function of 5PAHz, mimic of the 1,2-cis-enediolate function of the reaction intermediate of M6P to F6P reversible isomerization catalysed by the enzyme, is coordinated to the zinc cofactor in a bidentate manner. Consequently, this mode of coordination confers to zinc not only a structural role but also a catalytic role in the reaction process. The Zn binding mode of the 5PAHz inhibitor mimics the bidentate Zn coordination of substrate and HEI. It further explains the stereochemistry of the isomerase activity, and the absence of anomerase and C2-epimerase activities in Type I PMI. Crystal studies of CaPMI complexed to its cyclic substrates or other inhibitors are currently under investigation in order to determine their mode of interaction as well as whether or not PMI is involved in the ring opening/closing steps of the overall transformation.
Accession number
Coordinates and structure factors have been deposited in the Protein Data Bank with accession number 5NW7. 
